Penumbra Inc (PEN) is a Healthcare · Medical Devices company listed on NYSE. Price $318.75 (-0.04%), Market cap $12.65B, P/E ratio 74.13, 52-week low–high $225.54 ~ $359.40.
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion c
Financial statements, price targets, institutional (13F) holdings and related news for Penumbra Inc are updated in real time on BlackAll Trade.
Penumbra Inc trades at $318.75 (-0.04%). Real-time quotes and charts are available on BlackAll Trade.
Penumbra Inc has a market cap of about $12.65B. Its P/E ratio is 74.13.
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy;